You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

semaglutide

Showing 51 - 75 of 191
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers, Overweight, Obesity Trial in Neuss (Semaglutide)

Completed
  • Healthy Volunteers
  • +2 more
  • Semaglutide
  • Neuss, Germany
    Novo Nordisk Investigational Site
Jan 6, 2022

O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide
  • Ahmadi, Kuwait
  • +16 more
Jan 29, 2023

Retrospective Data of Glucagon-like Peptide-1 Participanta With

Recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide
  • Skopje, North Macedonia
    Novo Nordisk Investigational Site
Jul 22, 2022

Healthy Volunteers, Diabetes, Type 2 Trial in Mainz (Semaglutide)

Completed
  • Healthy Volunteers
  • Diabetes Mellitus, Type 2
  • Semaglutide
  • Mainz, Germany
    Novo Nordisk Investigational Site
Nov 9, 2021

Obesity or Overweight Trial in China (Cagrilintide, Semaglutide, Placebo Semaglutide)

Not yet recruiting
  • Obesity or Overweight
  • Beijing, Beijing, China
  • +24 more
Aug 10, 2023

Endometrial Hyperplasia Trial in Saint Louis (Semaglutide, Placebo, Progestin)

Not yet recruiting
  • Endometrial Hyperplasia
  • Semaglutide
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 24, 2023

Atheroscleroses, Coronary Trial (Semaglutide)

Not yet recruiting
  • Atheroscleroses, Coronary
  • Semaglutide
  • (no location specified)
Sep 27, 2021

Overweight, Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Completed
  • Overweight
  • +2 more
  • Semaglutide
  • Placebo (semaglutide)
  • Aparecida de Goiania, Goias, Brazil
  • +28 more
Jan 30, 2023

Obesity, Obese, Overweight or Obesity Trial in New Zealand (biological, drug, other)

Recruiting
  • Obesity
  • +2 more
  • Bimagrumab
  • +2 more
  • Anniston, Alabama
  • +23 more
Feb 1, 2023

HIV-1-infection, Adiposity, Insulin Resistance Trial in Brazil, United States (Semaglutide)

Active, not recruiting
  • HIV-1-infection
  • +4 more
  • Semaglutide
  • Birmingham, Alabama
  • +7 more
Dec 7, 2022

Diabetes, Type 2, Chronic Kidney Disease Trial in Worldwide (Semaglutide, Placebo (Semaglutide))

Recruiting
  • Diabetes Mellitus, Type 2
  • Chronic Kidney Disease
  • Semaglutide
  • Placebo (Semaglutide)
  • Tucson, Arizona
  • +33 more
Jan 17, 2023

Obesity or Overweight Trial in Japan, Taiwan (Cagrilintide, Semaglutide, Placebo Semaglutide)

Not yet recruiting
  • Obesity or Overweight
  • Koriyama-shi, Fukushima, Japan, Japan
  • +21 more
Apr 3, 2023

PCOS, Semaglutide, Taste, Altered Trial in Ljubljana (Semaglutide, Placebo)

Completed
  • PCOS
  • +5 more
  • Semaglutide
  • Placebo
  • Ljubljana, Slovenia
    UMC Ljubljana
Sep 28, 2021

Overweight, Obesity Trial in Neuss (Semaglutide)

Completed
  • Overweight
  • Obesity
  • Semaglutide
  • Neuss, Germany
    Novo Nordisk Investigational Site
Nov 10, 2021

Obesity, Albuminuria Trial in Worldwide (Semaglutide, Placebo)

Enrolling by invitation
  • Obesity
  • Albuminuria
  • Semaglutide
  • Placebo
  • Calgary, Alberta, Canada
  • +12 more
Mar 25, 2022

Healthy Volunteers Type 2 Diabetes Trial in Fukuoka (NNC0480-0389, Placebo (NNC0480-0389), Semaglutide)

Completed
  • Healthy Volunteers Type 2 Diabetes
  • Fukuoka, Japan
    Novo Nordisk Investigational Site
Sep 13, 2021

Obesity, Overweight Trial in Overland Park (NNC0174-0833, Semaglutide, Placebo (NNC0174-0833))

Completed
  • Obesity
  • Overweight
  • Overland Park, Kansas
    Novo Nordisk Investigational Site
Nov 16, 2021

Hepatobiliary Disorders, Non-alcoholic Fatty Liver Disease Trial in Mainz, Neuss (Semaglutide, Placebo)

Completed
  • Hepatobiliary Disorders
  • Non-alcoholic Fatty Liver Disease
  • Semaglutide
  • Placebo
  • Mainz, Germany
  • +1 more
Nov 12, 2021

Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide), Liraglutide)

Completed
Has Results
  • Overweight
  • Obesity
  • Semaglutide
  • +3 more
  • Birmingham, Alabama
  • +18 more
Apr 26, 2022

Klinefelter Syndrome Trial (Anastrozole, Semaglutide, human chorionic gonadotropin)

Not yet recruiting
  • Klinefelter Syndrome
  • (no location specified)
Oct 15, 2022

Stroke, Stroke, Acute, Stroke, Ischemic Trial in Linyi, Hong Kong (Semaglutide)

Recruiting
  • Stroke
  • +3 more
  • Semaglutide
  • Linyi, Shangdong, China
  • +1 more
Jun 24, 2023

Diabetes, Type 2 Trial in Neuss (NNC0148-0287sema, Semaglutide, NNC0148-0287)

Completed
  • Diabetes Mellitus, Type 2
  • Neuss, Germany
    Novo Nordisk Investigational Site
Sep 28, 2021

Covid19, Myocardial Injury Trial in Worldwide (semaglutide)

Recruiting
  • Covid19
  • Myocardial Injury
  • semaglutide
  • São Paulo, Brazil
  • +9 more
Jan 25, 2022

Looking at How Semaglutide Works in People With Type 2 Diabetes

Completed
  • Diabetes Mellitus, Type 2
  • Semaglutide
  • Cambridge, Ontario, Canada
    Novo Nordisk Investigational Site
Aug 31, 2021

Overweight, Obesity Trial in Japan, Korea, Republic of (Semaglutide, Placebo (semaglutide))

Completed
Has Results
  • Overweight
  • Obesity
  • Semaglutide
  • Placebo (semaglutide)
  • Adachi-ku, Tokyo, Japan
  • +27 more
Feb 23, 2022